We aimed to compare pathological features and treatment outcomes of growth hormone/prolactin (GH/PRL)-positive adenomas with GH-only adenomas.<h4>Methods</h4>We retrospectively analyzed 90 patients with acromegaly who underwent transsphenoidal surgery between 2010 and 2025. The gene discussed is GH1; the disease is adenoma.